• Order to parcel locker

    Order to parcel locker
  • easy pay

    easy pay
  • Reduced price
Sickle Cell Syndromes, An Issue of Hematology/Oncology Clinics of North America

Sickle Cell Syndromes, An Issue of Hematology/Oncology Clinics of North America

9780323986632
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
483.79 zł
411.22 zł Save 72.57 zł Tax included
Lowest price within 30 days before promotion: 411.22 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DHL, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
In this issue of Hematology/Oncology Clinics, guest editors Drs. Sophie Lanzkron and Jane Little bring their considerable expertise to the topic of Sickle Cell Syndromes. Top experts in the field cover key topics such as structural racism and impact on sickle cell disease (SCD); pathophysiology and biomarkers of SCD; genetic modifiers of SCD; allogeneic transplant and gene therapy:: reproductive health; chronic pain; and more.
Product Details
Elsevier
98079
9780323986632
9780323986632

Data sheet

Publication date
2022
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
152 x 229
Weight (g)
590
  • Structural Racism and Impact on Sickle Cell Disease: Sickle Cell Lives MatterSickle Cell Disease Pathophysiology and Related Molecular and Biophysical BiomarkersGenetic Modifiers of Sickle Cell DiseaseEconomics of Sickle Cell Disease and Evidence to Support Comprehensive CareQuality of Life in Sickle Cell Disease: What MattersChronic Pain: Prevalence and ManagementThe Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell DiseaseClinical Vignettes Part IClinical Vignettes Part IIThe Cardiopulmonary Complications of Sickle Cell DiseaseSickle Cell Disease and the Kidney: Filters Gone AwryGo the Distance: Reproductive Health Care for People with Sickle Cell DiseaseGenotyping and the Future of Transfusion in Sickle Cell DiseaseThe Evolving Landscape of Drug Therapies for Sickle Cell DiseaseAllogeneic Transplant and Gene Therapy: Evolving Toward a Cure
Comments (0)